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Dysregulation of calcium (Ca2+) homeostasis is now being recognized to be a key step
in the pathogenesis of Alzheimer’s disease (AD). Data from the literature, in particular
the association between AD and polymorphism that interfere with Ca2+ homeostasis
indicates the presence of genetic factors in this process; further, presenilins mutations,
which are known to cause the familial form of AD, are involved in the regulation of
intracellular Ca2+ stores. Here, we wish to draw attention to rare DNA copy number
variations identified in two subjects with late-onset AD that led to partial or full duplication
of genes that encode different subunits of the same type of voltage-gated Ca2+
channels; these duplications of voltage-gated Ca2+ channel genes is consistent with
the critical role of calcium signaling in molecular processes underlying memory as has
been demonstrated by several studies.
Keywords: Alzheimer’s disease, copy number variations, CNVs, array-CGH, Ca2+
It’s widely known that Ca2+ represents one of the most important second messengers in the
brain and plays an essential role in neuronal development, synaptic transmission and plasticity,
besides regulating various metabolic pathways (Striessnig et al., 2006). The regulation of Ca2+
homeostasis in the central nervous system is a very complex process involving proteins localized
in the plasma membrane, endoplasmic reticulum (ER), mitochondria, and cytoplasm that together
are responsible for maintaining a higher concentration of Ca2+ in the extracellular space (Berridge
et al., 2003). Notably, as demonstrated by several studies, a dysregulation in Ca2+ homeostasis is
associated with many pathological mechanisms, especially those related with neurodegenerative
disorders (Berridge, 2013; Sulzer and Surmeier, 2013).
Based on previous observations that intracellular Ca2+ levels are increased in aging neurons, it
has been suggested that a dysregulation of Ca2+ homeostasis could be a key step in the pathogenesis
of Alzheimer’s disease (AD; Small, 2009). In fact, this is the basis of the calcium hypothesis of AD,
which offers a potential correlation between β-amyloid (Aβ) toxicity and a progressive decline in
memory and neuronal cell death (Fedrizzi and Carafoli, 2011). The central idea is that activation
of the amyloidogenic pathway leads to a remodeling of the neuronal Ca2+ signaling, and this
remodeling usually appears as upregulated in AD, triggered by either an enhance in the entry of
external Ca2+ or a release from internal stores (Berridge, 2010).
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FIGURE 1 | Continued
Frontiers in Genetics | www.frontiersin.org 2 June 2016 | Volume 7 | Article 107
fgene-07-00107 June 11, 2016 Time: 12:9 # 3
Villela et al. CNV in Calcium Signaling Pathway
FIGURE 1 | Continued
Rare copy number variations (CNVs) implicated in voltage gate calcium channels detected in two individuals with late-onset Alzheimer’s disease.
The figure shows array-CGH results where each dot represents a probe. A genomic segment was considered duplicated or deleted when the log2 ratio of the
Test/Reference fluorescent intensities of a given region encompassing at least three probes was above 0.3 or below -0.3, respectively, (Images were extracted from
Genomic Workbench software). (A) Top shows array-CGH profile of chromosome 3 of Individual 1; the black box indicates the location of the microduplication on
the short arm of the chromosome; underneath a detailed view of the area comprised in the black box at 3p21.1; the image shows a 665 kb duplication containing
among other genes, CACNA1D and CACNA2D3, highlighted by a blue trace. (B) Top shows array-CGH profile of chromosome 3 of Individual 2; the black box
indicates the location of the microduplication on the short arm of the chromosome; underneath a detailed view of the area comprised in the black box at 3p21.31;
the image shows a 300 kb duplication containing among other genes, CACNA2D2, highlighted by a blue trace.
The Aβ peptide, present in the extracellular senile plaques,
is one of the hallmarks of the disease and its aggregation in
oligomers has been found to induce Ca2+ influx into neurons
functioning as channels and/or by activating channels in the
plasma membrane (Demuro et al., 2010). The Aβ oligomers
could form non-selective pores with high conductance for
Ca2+ but they could also alter the fluidity of the membrane
affecting the activity of several Ca2+ permeable channels,
including acetylcholine receptors, glutamate receptors, dopamine
receptors, and serotonin receptors (Eckert et al., 2005). On the
other hand, within the neurons, Aβ interacts with two types
of Ca2+ channels in the ER membrane that regulate calcium
release from internal stores: (i) ryanodine receptors (RyRs)
and (ii) inositol trisphosphate receptors (IP3Rs); this leads to
an increase of their opening and the amount of Ca2+ being
released by the ER (Chakroborty et al., 2009). It is relevant to
note, though, that data from literature demonstrate that genetic
factors may be crucial in the dysregulation of Ca2+ homeostasis
in AD. Presenilins mutations, which are known to cause the
familial form of AD, have been found to increase the release
of intracellular Ca2+ from internal stores (Honarnejad and
Herms, 2012; Bezprozvanny, 2013). The activity of the SERCA
pump, which is responsible for maintain the Ca2+ concentration
gradient across the ER membrane (higher inside) is enhanced
by the presenilins (Green et al., 2008). Additionally, there is
increasing evidence that presenilins may be leak channel. Tu
et al. (2006) reported that the mutated form of presenilin 1 (PS1)
reduces the passive leak in neurons resulting in an increase of
cytoplasmatic Ca2+.
Of particular interest, it was demonstrated that a
polymorphism in CALHM1 (Ca2+ homeostasis modulator-1)
was significantly associated with the sporadic form of the
disease in a case-control study (Dreses-Werringloer et al., 2008).
Based on its sequence similarity to the ionotropic glutamate
receptor NMDA, it has been proposed that this gene encodes
a glycoprotein that is a cerebral Ca2+ channel component,
which is localized both in the plasma membrane and ER,
and may also function as a leak channel (Dreses-Werringloer
et al., 2008). The expression of CALHM1 polymorphic variant
reduces Ca2+ entry and this reduced Ca2+ permeability would
increase the level of stored Ca2+ by reducing this putative
leak pathyway; consequently, a decreased intracelullar Ca2+
levels is observed (Dreses-Werringloer et al., 2008). The authors
also suggest a direct impact of CALHM1 on Aβ production.
Although some studies argue against the latter observation,
it seems that the problem is the different methods used for
analysis of the data (Bertram et al., 2008; Rubio-Moscardo
et al., 2013). Besides, even though it seems controversial
that in the familial form of AD an increase of intracellular
Ca2+ is observed while in the sporadic form studies report
a reduce in intracellular Ca2+ levels, dysregulation of Ca2+
homeostasis in the two forms of AD, as described above, arise by
different mechanisms, but what is pretty clear in the literature
is that dysregulation of Ca2+ homeostasis is a major feature
in AD.
More recently, a multicenter study reported a robust and
consistently significant enrichment for genes constituting the
calcium signaling pathway, especially those related to the
elevation of cytosolic calcium, in independent cohorts of young
and elderly participants (Heck et al., 2015). The authors also
showed that the same gene set identified in those participants
was significantly enriched in a very large case-control study of
sporadic AD, making evident that calcium signaling is crucial in
human memory processes, both in cognitive health and disease
(Heck et al., 2015).
In an investigation about the frequency of DNA copy number
variations (CNVs) in a cohort of 46 individual’s diagnosed post-
mortem with late-onset AD provided by the Brain Bank of
the Brazilian Aging Brain Study Group (BBBABSG; Grinberg
et al., 2007). We found two cases with rare microduplications
partially or fully affecting genes that encode different subunits
of the same type of voltage-gated Ca2+ channels, the L-type
(L-VGCC). One individual presented a genomic imbalance of
665 kb at 3p21.1 that incudes, among other genes, CACNA1D
and CACNA2D3 (Figure 1A). CACNA1D encodes the subunit
α1 (subtype 1D), which form the ion-conducting pore of the
L-VGCC, and CACNA2D3 is responsible for encoding the
subunit α-2δ, that influences the channels’ biophysical properties
by increasing the current amplitude and regulating the activation
and inactivation kinetics of the L-VGCC. On the other hand, the
other subject showed a genomic imbalance of 300 kb at 3p21.31
that encompass the CACNA2D2 gene, which acts similarly to
CACNA2D3, i.e., also encodes the subunit α-2δ of the L-VGCC
(Figure 1B). Both duplications have intragenic breakpoints;
depending on the resulting structure of the rearrangement, the
partial gene duplications can result in loss of function of the genes
involved.
To exclude that these rare CNVs (rare defined as frequency
<0.1% of population, based on the Database of Genomic
Variants – DGV) represent common variants in the Brazilian
population, we compile CNV data from more than 1,300
individuals studied by array-CGH in our laboratory for reasons
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other than dementia, such as cancer predisposition, deafness,
congenital abnormalities, and intellectual disability. The rare
CNVs documented in this study were never detected in any
of these subjects. Additionally, in contrary to the control
sample in this study, which consisted in individuals with no
anatomophatological signs of AD, this set of more than 1,300
individuals is supposedly similar to the population regarding
AD predisposition factors. In particular, despite some of the
other individuals investigated in our casuistic also presented rare
CNVs, these two cases are the only ones who showed copy
number changes in genes that constitute the calcium signaling
pathway. However, we cannot exclude that the remaining 44
individuals may have point mutations in relevant genes of
calcium signaling pathway that could not be observed due to a
limited resolution of array-CGH.
CNVs are recognized to be a prevalent form of common
genetic variation and represent a substantial proportion of total
genetic variability in human population. The functional impact
of CNVs has been demonstrated at all biological levels, from
cellular effects on gene expression to their association with several
types of complex traits and genetic diseases (Stankiewicz and
Lupski, 2010). To date, copy number changes in genes encoding
calcium-signaling molecules have been associated especially with
neuronal development disorders, such as autism (Rosenfeld et al.,
2010), psychiatric diseases (Lee et al., 2012), and amyotrophic
lateral sclerosis.
The present evidence is the first to highlight genomic
imbalances in genes that are known to encode important
calcium-signaling molecules, and link those CNVs to late-
onset AD. Of note, in the manuscript from Heck et al.
(2015) it was demonstrated that the same gene family of
CACNA1D, CACNA2D2, and CACNA2D3 was found to be
significantly enriched in patients with AD, which reinforces the
significance of our findings. The present data also contribute
adding new mutations in genes of calcium signaling pathway
and associate these mutations with AD since CACNA1D,
CACNA1D, CACNA2D2, and CACNA2D3 are not in the list
of genes studied by Heck et al. (2015). Thus, considering
the importance of L-VGCC in the central nervous system
and Ca2+ being such an important regulator of synaptic
plasticity, we could suppose that a disruption in CACNA1D,
CACNA2D3, and CACNA2D3 caused by CNVs may lead to
a dysregulation in Ca2+ homeostasis and contribute to the
pathogenesis of AD. Also, using the Variant Effect Predictor
(VEP) tool from Ensemble1 to predict the effects of these two
microduplications on genes, transcripts, and protein sequence,
as well as regulatory regions, we found that the most likely
consequence (34%) is amplification of the amount of transcript.
Therefore, this prediction suggests a possible upregulation of
Ca2+ signaling, which meets the central idea of the calcium
hypothesis of AD (Berridge, 2010). Yet, the crucial question of
whether the microduplications showed in this study constitutes a
predisposing risk factor for AD can only be answered by similar
investigations in large cohorts, which we hope will be stimulated
by this report. Also, we believe that the present evidence may
stimulate further functional studies and eventually confirm the
impact of these copy number changes in the pathogenesis
of AD.
In summary, we wish to draw attention to rare DNA CNVs
identified in two subjects with late-onset AD that led to partial
or full duplication of genes that encode different subunits of the
same type of voltage-gated Ca2+ channels and point out that
the present finding is consistent with the critical role of calcium
signaling in molecular processes underlying memory as has been
demonstrated by several studies.
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